Biocryst Pharmaceuticals Inc (BCRX)

Change in Working Capital

-$71.66M

TTM · Period ending: · USD

BCRX logo

BCRX Change in Working Capital

Latest reported-$71.66M
BCRX Change in Working Capital (-$300.00K → -$71.66M)
High-resolution chart · PNG

BCRX change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-56,898,000
-87,282,000
-32,401,000
-58,945,000
8,124,000
26,875,000
-872,000
-3,530,000
9,327,000
-7,551,000
19,015,000
1,305,000
3,808,000
-4,299,000
14,683,000
-3,270,263
-9,904,332
-3,628,782
-3,003,016
24,257,467
1,708,000
1,462,571
282,000
-1,176,092
948,044
333,181
-300,000
-100,000
-500,000
300,000
400,000
-300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.